(ONCT) - Analyst Ratings

(ONCT) – Analyst Ratings

Apr 15, 2024 06:49 AM Oncternal Therapeutics (ONCT) PT Lowered to $28 at H.C. Wainwright
Dec 4, 2023 08:48 AM Brookline Capital Markets Upgrades Oncternal Therapeutics (ONCT) to Buy
Sep 18, 2023 06:13 AM
Apr 4, 2023 09:13 AM
Apr 4, 2023 06:11 AM
Apr 4, 2023 03:36 AM
Apr 4, 2023 03:30 AM
Feb 21, 2023 08:14 AM
Dec 22, 2022 04:24 PM
Dec 22, 2022 06:32 AM
May 10, 2022 07:56 AM
Feb 24, 2022 05:30 AM
Apr 6, 2021 04:03 PM
Mar 30, 2021 08:44 AM
Feb 23, 2021 08:01 AM
Aug 10, 2020 06:34 AM